3 results match your criteria: "West Hospital of the Second Hospital of Shanxi Medical University[Affiliation]"
Network pharmacology- and molecular docking-based approaches to unveil the pharmacological mechanisms of dihydroartemisinin against esophageal carcinoma.
Front Genet
November 2022
Pharmacy Department, West Hospital of the Second Hospital of Shanxi Medical University, Taiyuan, China.
Dihydroartemisinin (DHA) is an active metabolite of artemisinin and its derivatives, which is a potent drug extensively applied in clinical treatment of malaria. The antitumor properties of DHA have received increasing attention. However, there is no systematic summary on the pharmacological mechanisms of DHA against esophageal carcinoma (ESCA).
View Article and Find Full Text PDFThe value of oral contrast-enhanced ultrasonography in the diagnosis of gastric tumors in the elderly.
Panminerva Med
December 2022
Department of Ultrasonography, West Hospital of the Second Hospital of Shanxi Medical University, Taiyuan, China.
CircVCAN/SUB1 up-regulates MYC/HSP90β to enhance the proliferation and migration of glioma cells.
Brain Res Bull
December 2021
Department of Neurosurgery, Shanxi Bethune Hospital Shanxi Academy of Medical Sciences, No.99 Longcheng Street, Xiaodian District, Taiyuan, 030000, Shanxi, China.
Background: Gliomas are the most malignant and aggressive form of brain tumors, and account for the majority of brain cancer related deaths. Previous studies have reported that SUB1 serves as a novel RBP, which is highly expressed in tumors.
Aim: In our research, we aimed at exploring the regulatory mechanism of SUB1 in glioma cells.